Our Opinion
Spyre Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
Supporting Evidence:
The company stated in the following press release that they use animals for product testing.
“The preclinical potency, selectivity, and drug-like properties of these investigational antibodies match our ideal product profiles. Further, the half-life extension observed in animal studies supports the potential for human dosing every other month or quarterly, which, if supported by clinical trial results, would be a significant improvement compared to today’s approved therapies. We are eager to initiate Phase 1 clinical studies in each program this year.” Read the following article
Company Description
Spyre Therapeutics, Inc., a preclinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. Spyre Therapeutics, Inc. was incorporated in 2013 and is based in Waltham, Massachusetts.
Company Website: https://www.spyre.com